How can manufacturers leverage the proposed legislation to deliver needed treatments to patients in a way that is sustainable for long-term returns? Cem Zorlular, CEO of Er-Kim Pharmaceuticals explores.
Cem Zorlular, CEO of Er-Kim Pharmaceuticals, shares his insights on how pharma manufacturers can better navigate the global commercialisation of treatments in an ever-changing landscape.
